Embryo Ventures
Overview
Embryo Ventures is a London-based venture capital firm that invests in pre-seed and seed stage companies with a focus on health, cities, and living.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| OSSTEC | Nov 2026 | VC Round | Lead |
| Staxy | Oct 2025 | Seed | Co-investor |
| Unravel Health | Oct 2026 | Pre Seed | Co-investor |
| Novara Therapeutics | Aug 2020 | Joint Venture | Co-investor |
| Pluvo | Jul 2020 | Seed | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Embryo Ventures based?
Embryo Ventures is headquartered in London, United Kingdom.
When was Embryo Ventures founded?
Embryo Ventures was founded in 2019.
How many portfolio companies does Embryo Ventures have?
Embryo Ventures has 6 portfolio companies in Caplight's dataset.
What are some companies in Embryo Ventures's portfolio?
Portfolio companies visible on Caplight include OSSTEC, Staxy, Unravel Health, Novara Therapeutics, Pluvo.
What was Embryo Ventures's most recent investment shown here?
Embryo Ventures's most recent investment in this portfolio sample was in OSSTEC in 2026.
What sectors does Embryo Ventures focus on?
Embryo Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Mobility, Transportation & Logistics, Healthcare & Life Sciences, Energy & Sustainability, Media, Entertainment & Gaming, Enterprise Software, Consumer & Commerce, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does Embryo Ventures focus on?
Embryo Ventures typically invests at the Early stage.